Global proteomic profiling reveals altered proteomic signature in schizophrenia serum (Q48536502)

12 February 2018

title

Global proteomic profiling reveals altered proteomic signature in schizophrenia serum (English)

1 reference

12 February 2018

0 references

S Bahn

1 reference

12 February 2018

Y Levin

1 reference

12 February 2018

L Wang

1 reference

12 February 2018

E Schwarz

1 reference

12 February 2018

D Koethe

1 reference

12 February 2018

F M Leweke

1 reference

12 February 2018

language of work or name

English

0 references

publication date

23 June 2009

1 reference

12 February 2018

published in

Molecular Psychiatry

1 reference

12 February 2018

volume

1 reference

12 February 2018

issue

1 reference

12 February 2018

page(s)

1088-1100

1 reference

12 February 2018

A systematic review of the incidence of schizophrenia: the distribution of rates and the influence of sex, urbanicity, migrant status and methodology

cites work

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

A systematic review of the prevalence of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

A genome-wide scan for linkage to chromosomal regions in 382 sibling pairs with schizophrenia or schizoaffective disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

Size of burden of schizophrenia and psychotic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

Biomarker discovery in biological fluids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

The human plasma proteome: history, character, and diagnostic prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

Higher dimensional (Hi-D) separation strategies dramatically improve the potential for cancer biomarker detection in serum and plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

Analysis and quantification of diagnostic serum markers and protein signatures for Gaucher disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

IgM are associated to Sp alpha (CD5 antigen-like)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

Structures of apolipoprotein A-II and a lipid-surrogate complex provide insights into apolipoprotein-lipid interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

Truncation of the amino terminus of human apolipoprotein A-I substantially alters only the lipid-free conformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

The membrane IgM-associated proteins MB-1 and Ig-beta are sufficient to promote surface expression of a partially functional B-cell antigen receptor in a nonlymphoid cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

Human apoA-I expression in CETP transgenic rats leads to lower levels of apoC-I in HDL and to magnification of CETP-mediated lipoprotein changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

Nuclear receptors and the control of metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

Acute-phase proteins and other systemic responses to inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

In the absence of the low density lipoprotein receptor, human apolipoprotein C1 overexpression in transgenic mice inhibits the hepatic uptake of very low density lipoproteins via a receptor-associated protein-sensitive pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

22R-hydroxycholesterol and 9-cis-retinoic acid induce ATP-binding cassette transporter A1 expression and cholesterol efflux in brain cells and decrease amyloid beta secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

Analysis of gene expression profile induced by hepatocyte nuclear factor 4alpha in hepatoma cells using an oligonucleotide microarray

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

Cholesterol binds to synaptophysin and is required for biogenesis of synaptic vesicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

Crystal structure of truncated human apolipoprotein A-I suggests a lipid-bound conformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

CCAAT box enhancer binding protein alpha (C/EBP-alpha) stimulates kappaB element-mediated transcription in transfected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

Regulation of serum amyloid A protein expression during the acute-phase response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

Cholesteryl ester transfer protein modulates the effect of liver X receptor agonists on cholesterol transport and excretion in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

Human ApoA-II inhibits the hydrolysis of HDL triglyceride and the decrease of HDL size induced by hypertriglyceridemia and cholesteryl ester transfer protein in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

Overexpression of APOC1 in obob mice leads to hepatic steatosis and severe hepatic insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

Ligand-induced conformational change in transferrins: crystal structure of the open form of the N-terminal half-molecule of human transferrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

Potential involvement of dissociated apoA-I in the ABCA1-dependent cellular lipid release by HDL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

Altered epitope expression of human interstitial fluid apolipoprotein A-I reduces its ability to activate lecithin cholesterol acyl transferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

In vivo protection against endotoxin by plasma high density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

Expression of human apolipoprotein A-I in transgenic mice results in reduced plasma levels of murine apolipoprotein A-I and the appearance of two new high density lipoprotein size subclasses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

Human ABCA7 supports apolipoprotein-mediated release of cellular cholesterol and phospholipid to generate high density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

Apolipoprotein A-I induces translocation of cholesterol, phospholipid, and caveolin-1 to cytosol in rat astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

Mechanisms of HDL deficiency in mice overexpressing human apoA-II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

ABCA1 and atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

Effects of enrichment of fibroblasts with unesterified cholesterol on the efflux of cellular lipids to apolipoprotein A-I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

Molecular cloning and expression of lipid transfer inhibitor protein reveals its identity with apolipoprotein F

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

Human plasma phospholipid transfer protein increases the antiatherogenic potential of high density lipoproteins in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

TFIIB-directed transcriptional activation by the orphan nuclear receptor hepatocyte nuclear factor 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

Apolipoprotein A-II/A-I ratio is a key determinant in vivo of HDL concentration and formation of pre-beta HDL containing apolipoprotein A-II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

Apolipoprotein L, a new human high density lipoprotein apolipoprotein expressed by the pancreas. Identification, cloning, characterization, and plasma distribution of apolipoprotein L

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

Cholesterol distribution in the Golgi complex of DITNC1 astrocytes is differentially altered by fresh and aged amyloid beta-peptide-(1-42).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

Overexpression of hepatic lipase in transgenic mice decreases apolipoprotein B-containing and high density lipoproteins. Evidence that hepatic lipase acts as a ligand for lipoprotein uptake.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

Lack of stimulation of cholesteryl ester transfer protein by cholesterol in the presence of a high-fat diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

Serum amyloid A generates high density lipoprotein with cellular lipid in an ABCA1- or ABCA7-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

Atherogenic, enlarged, and dysfunctional HDL in human PLTP/apoA-I double transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

Structure of human apolipoprotein D: locations of the intermolecular and intramolecular disulfide links

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

Evaluation of the mixed interaction between apolipoproteins A-II and C-I equilibrium sedimentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

Increased hepatobiliary and fecal cholesterol excretion upon activation of the liver X receptor is independent of ABCA1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

A two-step mechanism for free cholesterol and phospholipid efflux from human vascular cells to apolipoprotein A-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

Expression of the human apolipoprotein A-I gene in transgenic mice alters high density lipoprotein (HDL) particle size distribution and diminishes selective uptake of HDL cholesteryl esters

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

Disulfide bond assignment in human J chain and its covalent pairing with immunoglobulin M

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

In vivo evidence for both lipolytic and nonlipolytic function of hepatic lipase in the metabolism of HDL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

Glycosylation of endothelial lipase at asparagine-116 reduces activity and the hydrolysis of native lipoproteins in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

Sterols and isoprenoids: signaling molecules derived from the cholesterol biosynthetic pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

Atherosclerosis. the road ahead

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

The ligand-binding function of hepatic lipase modulates the development of atherosclerosis in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

An investigation into the human serum "interactome"

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

Biogenesis of HDL by SAA is dependent on ABCA1 in the liver in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

ABCG1 (ABC8), the human homolog of the Drosophila white gene, is a regulator of macrophage cholesterol and phospholipid transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

Resistance of SHP-null mice to bile acid-induced liver damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

Isolation and partial characterization of the inactive and active forms of human plasma phospholipid transfer protein (PLTP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

Mammalian ABC transporters in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

Sterol efflux to apolipoprotein A-I originates from caveolin-rich microdomains and potentiates PDGF-dependent protein kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

Apolipoprotein A-I alpha -helices 7 and 8 modulate high density lipoprotein subclass distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

Characterization of apolipoprotein-mediated HDL generation induced by cAMP in a murine macrophage cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

Cholesterol feeding of mice expressing cholesterol 7alpha-hydroxylase increases bile acid pool size despite decreased enzyme activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

Elevation of plasma phospholipid transfer protein in transgenic mice increases VLDL secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

Apolipoprotein CI deficiency markedly augments plasma lipoprotein changes mediated by human cholesteryl ester transfer protein (CETP) in CETP transgenic/ApoCI-knocked out mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

The structure of a human type III Fcgamma receptor in complex with Fc

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

Intracellular cholesterol mobilization involved in the ABCA1/apolipoprotein-mediated assembly of high density lipoprotein in fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

Alpha1-syntrophin modulates turnover of ABCA1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

Structural studies of a peptide activator of human lecithin-cholesterol acyltransferase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

ATP-binding cassette transporter A7 (ABCA7) binds apolipoprotein A-I and mediates cellular phospholipid but not cholesterol efflux

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

Gene transcription in hepatocytes during the acute phase of a systemic inflammation: from transcription factors to target genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

Overexpression of apoC-I in apoE-null mice: severe hypertriglyceridemia due to inhibition of hepatic lipase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

Hepatic cholesterol metabolism and resistance to dietary cholesterol in LXRbeta-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

Loss of functional farnesoid X receptor increases atherosclerotic lesions in apolipoprotein E-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

The N-terminal globular domain and the first class A amphipathic helix of apolipoprotein A-I are important for lecithin:cholesterol acyltransferase activation and the maturation of high density lipoprotein in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

Isolation and characterization of simple and complex lipoproteins containing apolipoprotein F from human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

Apolipoprotein-mediated cellular lipid release requires replenishment of sphingomyelin in a phosphatidylcholine-specific phospholipase C-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

Cholesteryl ester transfer protein expression attenuates atherosclerosis in ovariectomized mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

Novel putative SREBP and LXR target genes identified by microarray analysis in liver of cholesterol-fed mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

Cholesteryl ester transfer protein (CETP) expression protects against diet induced atherosclerosis in SR-BI deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

Severe hypertriglyceridemia in human APOC1 transgenic mice is caused by apoC-I-induced inhibition of LPL

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

Human apolipoprotein C-I accounts for the ability of plasma high density lipoproteins to inhibit the cholesteryl ester transfer protein activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

Proteolytic degradation and impaired secretion of an apolipoprotein A-I mutant associated with dominantly inherited hypoalphalipoproteinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

Substitutions of glutamate 110 and 111 in the middle helix 4 of human apolipoprotein A-I (apoA-I) by alanine affect the structure and in vitro functions of apoA-I and induce severe hypertriglyceridemia in apoA-I-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

Towards a proteome-scale map of the human protein–protein interaction network

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

Phosphorylation and stabilization of ATP binding cassette transporter A1 by synthetic amphiphilic helical peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

Structure of the gene encoding human alpha2-HS glycoprotein (AHSG)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

Functional LCAT deficiency in human apolipoprotein A-I transgenic, SR-BI knockout mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

Modulation of endosomal cholesteryl ester metabolism by membrane cholesterol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

The effects of mutations in helices 4 and 6 of ApoA-I on scavenger receptor class B type I (SR-BI)-mediated cholesterol efflux suggest that formation of a productive complex between reconstituted high density lipoprotein and SR-BI is required for ef

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

Activation of liver X receptors and retinoid X receptors prevents bacterial-induced macrophage apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

Independent protein-profiling studies show a decrease in apolipoprotein A1 levels in schizophrenia CSF, brain and peripheral tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

Gene expression analysis in schizophrenia: reproducible up-regulation of several members of the apolipoprotein L family located in a high-susceptibility locus for schizophrenia on chromosome 22.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

Differences in neuroanatomical sites of apoD elevation discriminate between schizophrenia and bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

Increased CNS levels of apolipoprotein D in schizophrenic and bipolar subjects: implications for the pathophysiology of psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

Proteomic analysis of the cerebrospinal fluid of patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

Crosstalk between nitric oxide and zinc pathways to neuronal cell death involving mitochondrial dysfunction and p38-activated K+ channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

Cholesterol and apolipoprotein E in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

Role of natural and immune IgM antibodies in immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

Review of immunological and immunopathological findings in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

Serum immunoglobulin levels in Chinese male schizophrenics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

Quantitative determination of immunoglobulins in CSF and plasma of chronic schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

A role for human Sp alpha as a pattern recognition receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

Molecular cloning, mapping to human chromosome 1 q21-q23, and cell binding characteristics of Spalpha, a new member of the scavenger receptor cysteine-rich (SRCR) family of proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

Alpha2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

Reference distributions for the negative acute-phase serum proteins, albumin, transferrin and transthyretin: a practical, simple and clinically relevant approach in a large cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

Protein analysis by mass spectrometry and sequence database searching: tools for cancer research in the post-genomic era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

7 January 2021

Label-free LC-MS/MS quantitative proteomics for large-scale biomarker discovery in complex samples

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

7 January 2021

Peptide correlation: a means to identify high quality quantitative information in large-scale proteomic studies

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

7 January 2021

Effects of site-directed mutagenesis on the serine residues of human lecithin:cholesterol acyltransferase

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

7 January 2021

Beneficial effects of fibrates on apolipoprotein A-I metabolism occur independently of any peroxisome proliferative response

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

7 January 2021

Plasma distribution of apoA-IV in patients with coronary artery disease and healthy controls

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

7 January 2021

Specific phospholipid association with apolipoprotein A-I stimulates cholesterol efflux from human fibroblasts. Studies with reconstituted sonicated lipoproteins

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

7 January 2021

Comprehensive proteomic profiling identifies serum proteomic signatures for detection of hepatocellular carcinoma and its subtypes

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

7 January 2021

Human cholesteryl ester transfer protein gene proximal promoter contains dietary cholesterol positive responsive elements and mediates expression in small intestine and periphery while predominant liver and spleen expression is controlled by 5'-dist

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

7 January 2021

Effect of apolipoprotein A-I lipidation on the formation and function of pre-beta and alpha-migrating LpA-I particles

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

7 January 2021

Both lipolysis and hepatic uptake of VLDL are impaired in transgenic mice coexpressing human apolipoprotein E*3Leiden and human apolipoprotein C1

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

7 January 2021

Interspecies activation of lecithin-cholesterol acyltransferase by apolipoprotein A-I isolated from the plasma of humans, horses, sheep, goats and rabbits

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

7 January 2021

Structural analysis of apolipoprotein A-I: limited proteolysis of methionine-reduced and -oxidized lipid-free and lipid-bound human apo A-I

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

7 January 2021

Differential interaction of the human cholesteryl ester transfer protein with plasma high density lipoproteins (HDLs) from humans, control mice, and transgenic mice to human HDL apolipoproteins. Lack of lipid transfer inhibitory activity in transgen

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

7 January 2021

Interaction of rat lecithin-cholesterol acyltransferase with rat apolipoprotein A-I and with lecithin-cholesterol vesicles

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

7 January 2021

Activation of lecithin-cholesterol acyltransferase by apolipoprotein D: comparison of proteoliposomes containing apolipoprotein D, A-I or C-I

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

7 January 2021

Interaction of human apolipoprotein A-I with dipalmitoylphosphatidylcholine in vesicular and micellar complexes

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

7 January 2021

Accumulation of cholestatic lipoproteins in ANIT-treated human apolipoprotein A-I transgenic rats is diminished through dose-dependent apolipoprotein A-I activation of LCAT

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

7 January 2021

Adipose tissue-specific CETP expression in mice: impact on plasma lipoprotein metabolism

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

7 January 2021

Cholesteryl ester transfer protein corrects dysfunctional high density lipoproteins and reduces aortic atherosclerosis in lecithin cholesterol acyltransferase transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

7 January 2021

Surface plasmon resonance biosensor studies of human wild-type and mutant lecithin cholesterol acyltransferase interactions with lipoproteins

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

7 January 2021

Activation of human plasma cholesteryl ester transfer protein by human apolipoprotein A-IV

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

7 January 2021

Recombinant models of lipoproteins. Apolipoprotein A-I/phosphatidylcholine/cholesterol complexes formed in a 2-chloroethanol-water mixture

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

7 January 2021

Plasma lipid transfer proteins

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

7 January 2021

Immunoglobulins, autoantibodies and other serum protein fractions in psychiatric disorders

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.54

7 January 2021

Identifiers

DOI

10.1038/MP.2009.54

1 reference

12 February 2018

1 reference

12 February 2018